Thursday, 8 June 2023
Trending

Investing

Needham & Company maintains Marvell at 'buy' with a price target of $65.00

Goldman Sachs Downgrades Elanco Animal Health to Sell



Needham & Company maintains Marvell at 'buy' with a price target of $65.00

Click Here to Read the Full Original Article at All News…